| III-67 Aurelia de Vries Schultink Therapeutic drug monitoring of endoxifen in ER-positive breast cancer patients: comparing data from clinical practice to model-based predictions. Thursday 09:55-11:30 |
| III-67 Aurelia de Vries Schultink Therapeutic drug monitoring of endoxifen in ER-positive breast cancer patients: comparing data from clinical practice to model-based predictions. Thursday 09:55-11:30 |